1. Catalogs
  2. Axis-Shield PLC
  3. DETECT IF P carinii (FIPC200)

DETECT IF P carinii (FIPC200)

DETECT IF P carinii (FIPC200)

DETECT IF P carinii (FIPC200)

Product catalog summary
Clinical Utility
Pneumocystis carinii is a common organism that infects humans and other mammals. It is particularly problematic in immunocompromised individuals, such as those with AIDS, where it can cause pulmonary infections and pneumonia. Despite a decrease in cases due to highly active anti-retroviral therapy (HAART), it remains the most prevalent opportunistic infection in HIV patients. The immunofluorescence technique has shown increased sensitivity for detecting P. carinii compared to traditional staining methods.
Product Description
The DETECT IF Pneumocystis carinii kit (Part Number: FIPC200) includes 60 tests. Additional components include positive control slides (MB-SL70-10) and positive/negative control slides (MB-SL75-10).
Intended Use
This test is an indirect qualitative immunofluorescence kit designed to detect P. carinii oocysts in human bronchoalveolar lavage fluid and induced sputum. It aids in diagnosing suspected P. carinii infections, with results to be interpreted alongside other clinical and diagnostic information. The method is simple, reliable, and typically provides results within one hour, offering clear and specific outcomes with minimal background fluorescence.
Ordering Information
The kit includes an anti-P. carinii monoclonal antibody (1mL), FITC-conjugate antibody (1mL), one lyophilized enzyme vial, dilute HCI (0.5mL), enzyme diluent (3mL), 25 specimen slides, and 6mL of mounting medium.
Contact Information
Axis-Shield, The Technology Park, Dundee DD2 1XA, Scotland UK. Phone: +44 (0)1382 422000, Fax: +44 (0)1382 422088, Email: [email protected], Website: www.axis-shield.com
See more

Catalog excerpts

DETECT IF P carinii (FIPC200)-1

DETECT IF Pneumocystis carinii

 Open the catalog to page 1
DETECT IF P carinii (FIPC200)-2

Clinical Utility P carinii is a widespread organism infecting man and other mammals. In immunocompromised patients, especially those with AIDS, it causes pulmonary infection and pneumonia. Although cases of Pneumocystis carinii pneumonia (PCP) have decreased since the introduction of highly active anti-retroviral therapy (HAART), PCP is still the most common opportunistic infection in patients with HIV infection. Studies have shown an increase in sensitivity for the detection of P carinii using the immunofluorescence technique over traditional staining methods. Intended Use The Detect IF Pneumocystis...

 Open the catalog to page 2

All Axis-Shield PLC catalogs and technical brochures

  1. HbA1c

    4  Pages

  2. HOMOCYSTEINE

    2  Pages

  3. ACTIVE-B12

    6  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.